Koyfin Home > Directory > Health Care > Aimmune Therap > Enterprise Value

Aimmune Therap Enterprise Value Chart (AIMT)

Aimmune Therap annual/quarterly Enterprise Value from 2015 to 2020.
  • Aimmune Therap Enterprise Value for the quarter ending September 09, 2020 was $2,085m a -0.06% decrease of -1m year over year
  • Aimmune Therap Enterprise Value for the last 12 months ending September 09, 2020 was $2,085m a -0.06% decrease of -1m year over year
  • Aimmune Therap Annual Enterprise Value for 2020 was $2,085m a 0.06% increase of 1m from 2019
  • Aimmune Therap Annual Enterprise Value for 2020 was $2,084m a -0.09% decrease of -2m from 2019
  • Aimmune Therap Annual Enterprise Value for 2020 was $2,086m a -0.03% decrease of -1m from 2019
Other Valuation Metrics:
  • Aimmune Therap Market Cap for the quarter ending March 03, 2018 was $1,841m a 43.79% increase of 806m year over year
  • Aimmune Therap Price / Book for the quarter ending March 03, 2018 was 9.15 a 57.27% increase of 5.24 year over year
View Chart On Koyfin

Quarterly AIMT Enterprise Value Data

09/2020$2,085m
09/2020$2,084m
09/2020$2,086m
09/2020$2,086m
09/2020$2,085m
09/2020$2,084m
09/2020$2,085m
09/2020$2,086m
09/2020$2,086m
09/2020$2,068m

Annual AIMT Enterprise Value Data

2020$2,085m
2020$2,084m
2020$2,086m
2020$2,086m
2020$2,085m
2020$2,084m
2020$2,085m
2020$2,086m
2020$2,086m
2020$2,068m